Logotype for Twist Bioscience Corporation

Twist Bioscience (TWST) investor relations material

Twist Bioscience Baird Global Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Twist Bioscience Corporation
Baird Global Healthcare Conference 2025 summary9 Sep, 2025

Business Overview and Technology

  • Miniaturized DNA synthesis on silicon chips enables scalable production of millions of DNA pieces, expanding into RNA and protein products.

  • Three business groups—SynbioWrite, NGS Read, and Biopharma Drug Discovery Services—leverage a unified silicon chip platform for diverse life sciences solutions.

  • Standardized, automated, and digitized production facilities, supported by a $1B infrastructure investment, drive operational efficiency and industrialized customization.

  • Direct sales, e-commerce, and OEM channels expand customer reach and support industrialized reagent production.

  • Company culture emphasizes technical expertise, customer understanding, high performance, and a diverse team with strong research and regulatory scale.

Financial Performance and Profitability

  • Revenue and gross margin have grown significantly, with gross margin improving from 34.4% in FY23Q3 to 53.4% in FY25Q3.

  • Adjusted EBITDA loss narrowed from $(29.6)M in Q3 2023 to $(8.0)M in Q3 2025, with breakeven targeted by end of fiscal 2026.

  • Operating expenses, including SG&A and R&D, have remained stable, supporting operational leverage and shrinking losses.

  • 75-80% of incremental revenue is dropping to gross margin, supporting profit expansion and disciplined capital allocation.

  • Non-GAAP financial measures supplement GAAP results, with reconciliations provided.

Synbio Business Trends

  • Synbio revenue grew 7% in Q3, nearly 20% excluding a large prior-year order, outpacing peers.

  • Market share gains are driven by differentiated products in speed, quality, and price, despite funding headwinds.

  • Express portfolio covers most gene products, offering five-day delivery and flexible pricing.

  • Customer ramp was slower than expected, but satisfaction and repeat business remain strong.

  • Product innovation continues to build on silicon chip investments, enhancing customer value.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Twist Bioscience earnings date

Logotype for Twist Bioscience Corporation
Q4 202517 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Twist Bioscience earnings date

Logotype for Twist Bioscience Corporation
Q4 202517 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. It offers synthetic DNA-based tools for research and development applications in life sciences. The company also provides molecular biology solutions comprising molecular cloning, next generation sequencing libraries, protein expression, and gene synthesis solutions; cytometry solutions; and biologics solutions for preclinical study. It serves the biotechnology research, pharmaceuticals and drug discovery, diagnostics, chemical manufacturing, agriculture industries, as well as contract research organizations and academic institutions.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage